Pfizer beats on earnings, but revenue misses as Covid product sales plummet

Pfizer is in a transition period as it pivots away from its blockbuster Covid vaccine and drug Paxlovid while the world emerges from the pandemic.

from Health and Science https://ift.tt/zvnerml
https://ift.tt/3gPL9Fl
https://ift.tt/xa2lnpG